Treatment outcomes in triple negative breast cancer patients undergoing neoadjuvant chemotherapy. The importance of Ki-67

被引：0
|
作者：
Rapoport, Bernardo Leon [1 ]
Barnard-Tidy, Jacqui [1 ]
van Eeden, Ronwyn [1 ]
Smit, Teresa [1 ]
Nayler, Simon [2 ]
Benn, Carol [3 ]
机构：
[1] Med Oncol Ctr Rosebank, Johannesburg, South Africa
[2] Gritzman & Thatcher Inc, Johannesburg, South Africa
[3] Netcare Breast Care Ctr, Johannesburg, South Africa
来源：
CANCER RESEARCH | 2020年 / 80卷 / 04期
关键词：
D O I：
10.1158/1538-7445.SABCS19-P2-16-20
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2-16-20
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Prognostic factors associated with pathological complete response in early breast cancer patients undergoing neoadjuvant chemotherapy. The importance of Ki-67 and molecular subtype
    Rapoport, B. L.
    Barnard-Tide, J.
    Smit, T.
    Nayler, S.
    Benn, C-A
    CANCER RESEARCH, 2019, 79 (04)
  • [2] Ki-67 as a Predictor of Response to Neoadjuvant Chemotherapy in Breast Cancer Patients
    Kim, Kwan Il
    Lee, Kyung Hee
    Kim, Tae Ryung
    Chun, Yong Soon
    Lee, Tae Hoon
    Park, Heung Kyu
    JOURNAL OF BREAST CANCER, 2014, 17 (01) : 40 - 46
  • [3] Ki-67 as predictor of chemotherapy response in neoadjuvant chemotherapy for breast cancer
    Mishra, A. K.
    Kapoor, A.
    Tewari, S.
    Gond, S.
    Kumar, R.
    BREAST, 2015, 24 : S90 - S90
  • [4] Prognostic function of Ki-67 for pathological complete response rate of neoadjuvant chemotherapy in triple-negative breast cancer
    Zhang, Guojing
    Xie, Wanqing
    Liu, Zhaozhe
    Lin, Chao
    Piao, Ying
    Xu, Long
    Guo, Fang
    Xie, Xiaodong
    TUMORI JOURNAL, 2014, 100 (02): : 136 - 142
  • [5] Ki-67, p53, and clinical outcomes of patients with triple-negative breast cancer
    Nishiyama, Yasuyuki
    Nishimura, Reiki
    Osako, Tomofumi
    Okumura, Yasuhiro
    Arima, Nobuyuki
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (27)
  • [6] Assessment of the Predictive Role of Ki-67 in Breast Cancer Patients Responses to Neoadjuvant Chemotherapy
    Rais, Ghizlane
    Mokfi, Rania
    Boutaggount, Farah
    Maskrout, Meryem
    Bennour, Soundouss
    Senoussi, Chaymae
    Rais, Fadoua
    EUROPEAN JOURNAL OF BREAST HEALTH, 2024, 20 (03) : 199 - 206
  • [7] Value of Ki-67 in prediction of response to neoadjuvant chemotherapy in breast cancer
    Kim, Kwanil
    Lee, Kyunghee
    Park, Heungkyu
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [8] Prognostic factors associated with pathological complete response in early breast cancer patients undergoing neoadjuvant chemotherapy: The importance of Ki-67 and molecular subtype
    Rapoport, B. L.
    Barnard-Tidy, J. A.
    Smit, T.
    Nayler, S. J.
    Benn, C. A.
    ANNALS OF ONCOLOGY, 2018, 29
  • [9] Change of Ki-67 after long course of neoadjuvant chemotherapy as prognostic factors in patients with stage II, III triple negative breast cancer
    Yang, Yaewon
    Kim, Tae-Yong
    Im, Seock-Ah
    Keam, Bhumsuk
    Lee, Kyung-Hun
    Han, Sae-Won
    Oh, Do-Youn
    Kim, Tae-You
    Moon, Hyeong-Gon
    Han, Wonshik
    Park, In Ae
    Noh, Dong-Young
    CANCER RESEARCH, 2015, 75
  • [10] Pathological complete response in early breast cancer patients undergoing neoadjuvant chemotherapy: Focus on Ki-67 and molecular subtypes
    Rapoport, B. L.
    Barnard-Tidy, J.
    Van Eeden, R. I.
    Smit, T.
    Nayler, S.
    Benn, C.
    ANNALS OF ONCOLOGY, 2019, 30 : 37 - 37
12345